/x/	Not applicable.

(a)	/ /	Broker or dealer registered under Section 15 of the Exchange Act.

(b)	/ /	Bank as defined in Section 3(a)(6) of the Exchange Act.

(c)	/ /	Insurance company as defined in Section 3(a)(19) of the Exchange Act.

(d)	/ /	Investment company registered under Section 8 of the Investment Company Act.

(e)	/ /	An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).

(f)	/ /	An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).

(g)	/ /	A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).

(h)	/ /	A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.

(i)	/ /	A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act.

(j)	/ /	Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

(k)	/ /	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

Item 4.

Ownership

(a)

Amount beneficially owned:

As of the close of business on November
30, 2017, (i) BVF beneficially owned 2,691,120 shares of Common Stock, (ii) BVF2 beneficially owned 1,718,193 shares of Common
Stock, (iii) Trading Fund OS beneficially owned 459,326 shares of Common Stock and (iv) 558,674 shares of Common Stock were held
in certain Partners managed accounts (the “Partners Managed Accounts”).

Partners OS, as the general partner
of Trading Fund OS may be deemed to beneficially own the 459,326 shares of Common Stock beneficially owned by Trading Fund OS.

10

Follow Cytokinetics Inc (NASDAQ:CYTK)

We may use your email to send marketing emails about our services. Click here to read our privacy policy.

<< Prev

Page 10 of 13

Next >>

See All

NASDAQ:CYTK SEC 13G Filing Cytokinetics Inc (CYTK)Biotechnology Value Fund L P

13G Filing: Biotechnology Value Fund LP and Cytokinetics Inc (CYTK)

Published on December 1, 2017 at 10:38 am by Insider Monkey Staff in Hedge Funds

Page 10 of 13 – SEC Filing

Follow Cytokinetics Inc (NASDAQ:CYTK)

Follow Cytokinetics Inc (NASDAQ:CYTK)

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Published on February 25, 2025 at by Inan Dogan, PhD

A New Dawn is Coming to U.S. Stocks

Published on January 7, 2025 at by Insider Monkey Staff